P&G Hygiene and Health Care has announced that its board of directors will convene on January 30, 2026, to consider the declaration of an interim dividend for the Financial Year 2025-26. The company made this disclosure through a regulatory filing dated January 21, 2026, addressed to both the Bombay Stock Exchange and National Stock Exchange of India.

Board Meeting Details

The upcoming board meeting represents an update to the company's previous communication dated December 26, 2025. The January 21, 2026 filing specifically adds the consideration of interim dividend declaration to the board's agenda for the scheduled meeting.

Regulatory Compliance

The announcement was made under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was signed by Flavia Machado, serving as the company's authorized signatory, and was digitally authenticated on January 21, 2026.

Company Information

Procter & Gamble Hygiene and Health Care Limited operates with CIN L24239MH1964PLC012971 and maintains its registered office at P&G Plaza, Cardinal Gracias Road, Chakala, Andheri (E), Mumbai 400099. The company's shares are listed on major Indian stock exchanges with specific scrip codes for trading purposes.

Market Communication

The regulatory filing serves as an official update to stakeholders and the investment community regarding the board's expanded agenda. The company has requested stock exchanges to take note of this development and maintain it on record as part of standard disclosure procedures.

P&G Hygiene and Health Care Ltd (PGHH) has announced its unaudited financial results for the quarter ended September 30, 2025, revealing the company's performance in its two main segments: Health Care Products and Hygiene Products.

Financial Results Overview

The Board of Directors approved the results at a meeting held on November 6, 2025. Key financial highlights include:

Segment Operations

PGHH operates in two main segments:

1. Health Care Products: Comprising ointments, creams, cough drops, and tablets
2. Hygiene Products: Including feminine hygiene products and other skin care hygiene items

Financial Position

As of September 30, 2025, PGHH's financial position remains strong:

• Cash and Cash Equivalents: ₹782.10 crore
• Total Assets: ₹2,133.41 crore
• Total Equity: ₹931.27 crore

Audit and Review

The financial results were reviewed by the Audit Committee and have been subject to limited review by statutory auditors.

Change in Financial Year

The company changed its financial year from June 30 to March 31, with the previous financial year 2024-25 covering nine months from July 1, 2024, to March 31, 2025.

Investors and stakeholders may closely monitor how PGHH navigates market conditions in the coming quarters, balancing revenue growth with profitability and operational efficiency across its key product categories.